| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.45 | 0.0004 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |